Publication | Open Access

Antiproliferative activity of vitexin-2-O-xyloside and avenanthramides on CaCo-2 and HepG2 cancer cells occurs through apoptosis induction and reduction of pro-survival mechanisms

Apoptosis InductionAntiproliferative ActivityMedicineOncogenic AgentApoptosisCell DeathHepg2 Cancer CellsAnti-cancer AgentPharmacologyRadiation OncologyTumor MicroenvironmentCancer Research